InforCapital Advisory Learn more →
InforCapital
Sign In

VC Deal Database

Therapeutics VC Deals

Startup fundraising rounds in the Therapeutics subsector.

Never miss a deal

Get instant notifications when new VC deals matching "Therapeutics" are published.

Filters

31 shown

Date:Aug 20, 2026

Remepy

Remepy Raises $36M for AI-Enhanced Parkinson's Drug
Investors:
Merck KGaA, Darmstadt, Germany
Round:Series A
Amount:$36.0M
Valuation:—
Country:🇮🇱
Date:Aug 20, 2026

LifeMine Therapeutics

LifeMine Therapeutics Raises $263M for Drug Discovery
Investors:
Milky Way Investments, Bezos Expeditions, Gates Frontier+6 more
Round:Series E
Amount:$263.0M
Valuation:—
Country:🇺🇸
Date:Aug 20, 2026

Network Bio

Network Bio Raises $50M for AI Disease Modeling
Investors:
Section 32, Thiel Bio, Founders Fund+3 more
Round:Series A
Amount:$50.0M
Valuation:—
Country:🇺🇸
Date:Aug 20, 2026

KaliVir Immunotherapeutics

KaliVir Immunotherapeutics Raises $14M Series A Extension
Investors:
Company K Partners, SV Investment, Flexus Partners+2 more
Round:Series A
Amount:$14.0M
Valuation:—
Country:🇺🇸
Date:Aug 18, 2026

Leal Therapeutics

Leal Therapeutics Raises $30M for Neuro-Metabolic Drug Development
Investors:
Eli Lilly and, OrbiMed, Newpath Partners+5 more
Round:Series A
Amount:$30.0M
Valuation:—
Country:🇺🇸
Date:Aug 18, 2026

Leal Therapeutics

Leal Therapeutics Raises $30M for Schizophrenia Drug Development
Investors:
Eli Lilly, OrbiMed, Newpath Partners+5 more
Round:Series A
Amount:$30.0M
Valuation:—
Country:🇺🇸
Date:Aug 18, 2026

Leal Therapeutics

Leal Therapeutics Raises $30M for CNS Drug Development
Investors:
Eli Lilly and, OrbiMed, Newpath Partners+5 more
Round:Series A
Amount:$30.0M
Valuation:—
Country:🇺🇸
Date:Aug 18, 2026

University of Glasgow spinouts

Glasgow University Spinouts Seek Seed Funding
Investors:—
Round:—
Amount:n/a
Valuation:—
Country:🇬🇧
Date:Aug 16, 2026

Amplifica Holdings Group

Amplifica Raises $26M for Injectable Hair Growth Therapies
Investors:
Eli Lilly and
Round:Series B
Amount:$26.0M
Valuation:—
Country:🇺🇸
Date:Aug 16, 2026

Epicrispr Biotechnologies

Epicrispr Biotechnologies Raises $90M for FSHD Therapy
Investors:
Octagon Capital, Janus Henderson Investors, Angelini Ventures+6 more
Round:Series C
Amount:$90.0M
Valuation:—
Country:🇺🇸
Date:Aug 16, 2026

Replimune

Replimune Raises $150M for TUDRIQEV Launch & Trial
Investors:—
Round:Growth
Amount:$150.0M
Valuation:—
Country:🇺🇸
Date:Aug 16, 2026

Epicrispr Biotechnologies

Epicrispr Raises $90M for Epigenetic FSHD Therapy
Investors:
Octagon Capital, Janus Henderson Investors, Fidelity Management & Research+6 more
Round:Series C
Amount:$90.0M
Valuation:—
Country:🇺🇸
Date:Aug 16, 2026

Cambridge Aerospace

UK Tech Funding Roundup: £368M Deployed
Investors:
DFJ Growth, Lux Capital, Accel+29 more
Round:—
Amount:n/a
Valuation:—
Country:🇬🇧 🇺🇸
Date:Aug 13, 2026

Vaderis Therapeutics

Vaderis Raises $152M for Rare Disease Drug Development
Investors:
Goldman Sachs Alternatives, TCGX, EQT Life Sciences+5 more
Round:Series B
Amount:$152.0M
Valuation:—
Country:🇨🇭
Date:Aug 13, 2026

Khartis Therapeutics

Khartis Therapeutics Raises $50M for Immune Disease Drug Pipeline
Investors:
Forge Life Science Partners, Longwood Fund, Alexandria Venture Investments+3 more
Round:Series B
Amount:$50.0M
Valuation:—
Country:🇺🇸
Date:Aug 13, 2026

Tango Therapeutics

Tango Therapeutics Secures $1 Billion for Cancer Drug Development
Investors:—
Round:—
Amount:$1.0B
Valuation:—
Country:🇺🇸
Date:Aug 13, 2026

Erasca

Erasca Raises $891M for Oncology Drug ERAS-0015
Investors:—
Round:—
Amount:$891.3M
Valuation:—
Country:🇺🇸
Date:Aug 13, 2026

Aleris Therapeutics

Australian Biotechs Gain $13.5M for Health Tech Advances
Investors:
MTPConnect, NRF
Round:—
Amount:$13.5M
Valuation:—
Country:🇦🇺
Date:Aug 13, 2026

Remepy

Remepy Raises $36M Series A for Hybrid Drug Development
Investors:
O.G. Venture Partners, M Ventures, NFX+9 more
Round:Series A
Amount:$36.0M
Valuation:—
Country:🇺🇸
Date:Aug 12, 2026

Boulevard Bio

Boulevard Bio Raises $65M for Autoimmune Disease Treatments
Investors:
Deerfield Management
Round:Series A
Amount:$65.0M
Valuation:—
Country:🇺🇸
Date:Aug 12, 2026

Beyang Therapeutics

Beyang Therapeutics Raises $30M for Drug R&D
Investors:—
Round:Series A
Amount:$30.0M
Valuation:—
Country:🇨🇳
Date:Aug 12, 2026

Vedanta Biosciences

Vedanta Biosciences Nets $60M for Microbiome Drug Development
Investors:
AMR Action Fund, BNP Paribas Asset Management Alts
Round:—
Amount:$60.0M
Valuation:—
Country:🇺🇸
Date:Aug 11, 2026

BioThera Solutions

BioThera Solutions Raises Seed Funding for EV Therapeutics
Investors:
NRC Industrial Research Assistance Program
Round:Seed
Amount:$1.5M
Valuation:—
Country:🇨🇦 🇺🇸
Date:Aug 11, 2026

Vaderis Therapeutics

EQT Leads $152M Round for Vaderis Therapeutics' Rare Disease Drug
Investors:
EQT Life Sciences, Life Sciences at Goldman Sachs Alternatives, TCGX+5 more
Round:Series B
Amount:$152.0M
Valuation:—
Country:🇨🇭 🇺🇸
Date:Aug 11, 2026

Vaderis Therapeutics

Vaderis Therapeutics Raises $152M for Rare Disease Drug
Investors:
Goldman Sachs Alternatives, TCGX, Omega Funds+5 more
Round:Series B
Amount:$152.0M
Valuation:—
Country:🇨🇭 🇺🇸
Date:Aug 11, 2026

Aureka Biotechnologies

Aureka Biotechnologies Raises $100M for AI Drug Discovery
Investors:
Granite Asia, HighLight Capital, MPCi+1 more
Round:Series B
Amount:$100.0M
Valuation:—
Country:🇺🇸 🇨🇳
Date:Aug 11, 2026

Remedium Bio

Remedium Bio Raises $10M for Protein Therapy Platform
Investors:
Lifespan Vision Ventures, Eli Lilly and, HKX Capital
Round:Series A
Amount:$10.0M
Valuation:—
Country:🇺🇸
Date:Aug 11, 2026

Expedition Therapeutics

Expedition Therapeutics Closes $115M Series B Funding Round
Investors:
General Atlantic, RA Capital, Vivo Capital+10 more
Round:Series B
Amount:$115.0M
Valuation:—
Country:🇺🇸
Date:Aug 10, 2026

Mironid

Mironid Raises £34M for Rare Kidney Disease Therapy
Investors:
Scottish National Investment Bank, Roche Venture Fund, Epidarex Capital+3 more
Round:Series B
Amount:$46.0M
Valuation:—
Country:🇬🇧
Date:Aug 10, 2026

Expedition Therapeutics

Expedition Therapeutics Raises $115M Series B
Investors:
General Atlantic, RA Capital, Vivo Capital+10 more
Round:Series B
Amount:$115.0M
Valuation:—
Country:🇺🇸
Date:Aug 8, 2026

Mironid

Mironid Raises €39.9M for Rare Kidney Disease Drug Development
Investors:
Scottish National Investment Bank, Roche Venture Fund, Epidarex Capital
Round:Series B
Amount:$46.0M
Valuation:—
Country:🇬🇧

Never Miss a Deal

Get weekly investment intelligence. Free forever.

You reached the end (31 deals).